Protara Therapeutics Inc

Stock Chart, Company Information, and Scan Results

$6.76(as of Nov 18, 4:08 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Protara Therapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$6.76
Ticker SymbolTARA
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees28
CountyUSA
Market Cap$214.9M

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy for patients receiving parenteral nutrition and fluids. The company is headquartered in New York, New York.

Protara Therapeutics Inc In Our Stock Scanner

As of Nov 19, 2025
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.